Tag Archives: Hercules Capital

Hercules Capital Provides $235MM to Corium, Surpasses $1.5B in Commitments in 2021

Corium, a commercial-stage biopharmaceutical company, closed on a $235 million term loan agreement with Hercules Capital. Hercules Capital also reported it has originated more than $1.5 billion year to date in annual total gross debt and equity commitments in 2021, breaking its previous one-year record.

Hercules Capital Provides $30MM Debt Facility to HiberCell

HiberCell, a biotechnology company developing therapeutics for the prevention of cancer relapse and metastasis, closed on a $30 million debt facility with Hercules Capital. In addition, HiberCell completed a Series B financing round for gross proceeds of $67.4 million.